RecruitingNCT06793111

Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)

Visceral Leishmaniasis in Emilia-Romagna


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

300 participants

Start Date

Apr 21, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

According to reports in the literature, from 2012 to date, there has been an increase in the number of diagnosed cases of autochthonous visceral Leishmania in the Province of Bologna. In this context, it was decided to carry out a retrospective prospective observational study, which is essential to describe the epidemiology of LV in order to outline the scientific and rational bases necessary for the drafting of guidelines to standardise the diagnostic and therapeutic approach to this disease, in order to reduce the diagnostic delay and improve therapeutic results. therapeutic outcome. In addition, epidemiological data will make it possible to identify possible new strategies to control the disease, which are essential for reducing its transmission.


Eligibility

Min Age: 6 YearsMax Age: 90 Years

Inclusion Criteria2

  • Patients of any age with microbiologically established diagnosis of LV.
  • Obtaining Informed Consent.

Exclusion Criteria1

  • not having obtained Informed Consent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

Ospedale M. Bufalini di Cesena, AUSL della Romagna

Cesena, Forlì-Cesena, Italy

Ospedale G.B. Morgagni L. Pierantoni di Forlì

Forlì, Forlì-Cesena, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy

Ospedale S. Maria delle Croci di Ravenna, AUSL della Romagna

Ravenna, Italy

Ospedale Infermi di Rimini, AUSL della Romagna

Rimini, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06793111


Related Trials